Landos Biopharma (LABP) Stock Chart & Stock Price History → Your Money is Not Safe (From American Alternative) (Ad) Free LABP Stock Alerts $21.48 +0.12 (+0.56%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Landos Biopharma Stock Price Performance5 Day Performance+174.33%1 Month Performance+238.80%3 Month Performance+486.89%6 Month Performance+453.61%Year-To-Date Performance+486.89%1 Year Performance+666.32% Receive LABP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American AlternativeYour Money is Not SafeBiden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW LABP Stock Chart for Friday, March, 29, 2024 LABP Chart by TradingView Landos Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$21.36$21.50+0.66%$21.82$21.3547,101 shs$67.08 million03/27/2024$21.56$21.36-0.93%$21.64$21.3544,644 shs$66.64 million03/26/2024$21.41$21.56+0.70%$21.80$21.3666,055 shs$67.27 million03/25/2024$7.83$21.41+173.44%$21.87$21.11570,043 shs$66.80 million03/22/2024$7.67$7.83+2.09%$8.08$7.707,105 shs$24.43 million03/21/2024$6.99$7.67+9.73%$7.90$7.0010,985 shs$23.93 million Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$6.94$6.99+0.72%$7.29$6.903,924 shs$21.81 million03/19/2024$6.64$6.94+4.52%$7.35$6.6418,645 shs$21.63 million03/18/2024$6.64$6.64$6.68$6.3110,867 shs$20.72 million03/15/2024$6.48$6.64+2.47%$6.64$6.302,837 shs$20.72 million03/14/2024$6.48$6.48$6.60$6.266,083 shs$20.20 million03/13/2024$6.53$6.48-0.77%$6.68$6.254,915 shs$20.22 million03/12/2024$6.25$6.53+4.48%$6.53$6.065,071 shs$20.37 million03/11/2024$6.24$6.25+0.16%$6.68$5.5721,315 shs$19.50 million03/08/2024$6.51$6.24-4.15%$6.64$6.0123,637 shs$19.47 million03/07/2024$6.61$6.51-1.51%$6.58$6.0047,492 shs$20.31 million03/06/2024$6.51$6.61+1.54%$6.73$6.413,906 shs$20.62 million03/05/2024$6.57$6.51-0.91%$6.63$6.395,736 shs$20.29 million03/04/2024$6.35$6.57+3.46%$6.57$6.2713,858 shs$20.50 million03/01/2024$6.34$6.35+0.16%$6.55$6.246,660 shs$19.81 million02/29/2024$6.36$6.34-0.31%$6.51$6.2017,412 shs$19.78 million02/28/2024$6.37$6.36-0.16%$6.38$6.202,242 shs$19.84 million02/27/2024$6.24$6.37+2.08%$6.41$6.1512,539 shs$19.87 million02/26/2024$6.29$6.24-0.79%$6.45$6.0125,301 shs$19.47 million02/23/2024$5.78$6.29+8.82%$6.45$5.8356,570 shs$19.63 million02/22/2024$5.78$5.78$5.78$5.3813,233 shs$18.03 million02/21/2024$5.73$5.78+0.87%$5.89$5.576,958 shs$18.03 million02/20/2024$5.60$5.73+2.32%$5.80$5.4221,067 shs$17.86 million02/19/2024$5.60$5.60$5.60$5.60800 shs$17.47 million02/16/2024$5.46$5.51+0.92%$5.60$5.42816 shs$17.19 million02/15/2024$5.29$5.46+3.21%$5.47$5.259,039 shs$17.02 million02/14/2024$5.21$5.29+1.54%$5.47$5.168,855 shs$16.51 million02/13/2024$5.40$5.21-3.52%$5.47$4.838,447 shs$16.26 million02/12/2024$5.18$5.40+4.25%$5.40$5.252,303 shs$16.85 million02/09/2024$5.18$5.31+2.51%$5.31$5.164,436 shs$16.57 million02/08/2024$5.20$5.18-0.38%$5.31$5.161,931 shs$16.16 million02/07/2024$5.33$5.20-2.44%$5.30$5.203,364 shs$16.22 million02/06/2024$5.45$5.33-2.20%$5.41$5.223,283 shs$16.63 million02/05/2024$5.28$5.45+3.22%$5.62$5.2322,592 shs$16.99 million02/02/2024$5.39$5.28-2.04%$5.40$4.606,105 shs$16.47 millionYour Money is Not Safe (Ad)Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…CLICK HERE TO GET YOUR GUIDE NOW02/01/2024$5.39$5.39$5.46$5.0810,850 shs$16.82 million01/31/2024$4.98$5.39+8.23%$5.47$4.889,341 shs$16.80 million01/30/2024$5.00$4.98-0.40%$5.13$4.687,042 shs$15.54 million01/29/2024$4.61$5.00+8.46%$5.24$4.6554,997 shs$15.60 million01/26/2024$4.78$4.61-3.56%$4.93$4.394,581 shs$14.37 million01/25/2024$4.55$4.78+5.05%$4.78$4.377,684 shs$14.91 million01/24/2024$4.68$4.55-2.78%$4.88$4.553,702 shs$14.20 million01/23/2024$4.85$4.68-3.51%$4.94$4.462,340 shs$14.60 million01/22/2024$4.72$4.85+2.86%$4.85$4.585,609 shs$15.13 million01/19/2024$4.75$4.72-0.63%$4.72$4.384,844 shs$14.73 million01/18/2024$4.40$4.75+7.95%$4.79$4.3036,711 shs$14.82 million01/17/2024$4.24$4.40+3.77%$4.40$4.157,705 shs$13.73 million01/16/2024$4.36$4.24-2.75%$4.40$4.213,538 shs$13.22 million01/15/2024$4.36$4.36+0.11%$4.40$4.352,300 shs$13.60 million01/12/2024$4.39$4.36-0.71%$4.40$4.352,372 shs$13.60 million01/11/2024$4.39$4.39$4.40$4.292,650 shs$13.69 million01/10/2024$4.39$4.39+0.02%$4.40$4.292,650 shs$13.70 million01/09/2024$4.40$4.39-0.23%$4.40$4.38598 shs$13.70 million01/08/2024$4.39$4.40+0.23%$4.40$4.233,391 shs$13.73 million01/05/2024$4.40$4.39-0.23%$4.40$4.39314 shs$13.68 million01/04/2024$4.47$4.40-1.57%$4.49$4.064,530 shs$13.73 million01/03/2024$4.32$4.47+3.47%$4.47$4.005,835 shs$13.95 million01/02/2024$3.66$4.32+18.03%$4.53$3.7510,995 shs$13.48 million01/01/2024$3.66$3.66$3.80$3.536,200 shs$11.42 million12/29/2023$3.48$3.66+5.17%$3.80$3.496,248 shs$11.42 million12/28/2023$3.59$3.48-3.06%$3.50$3.405,065 shs$10.86 million Related Companies: MediciNova Stock Price Chart Anebulo Pharmaceuticals Stock Price Chart Journey Medical Stock Price Chart Eagle Pharmaceuticals Stock Price Chart Kezar Life Sciences Stock Price Chart vTv Therapeutics Stock Price Chart Immuneering Stock Price Chart Korro Bio Stock Price Chart Kronos Bio Stock Price Chart Assembly Biosciences Stock Price Chart Receive LABP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LABP) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaOnly a fool would buy Nvidia today… Porter & CompanyThe ONE AI Sock to own now. (It’s not Nvidia.)Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.